FdaApplication
ANDA 213573
Identifiers
- fda_app_no: ANDA213573
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2024-04-02 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 0.4MG/ML | INJECTABLE;INJECTION |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 1MG/ML | INJECTABLE;INJECTION |
2 products